Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-10, Stock:ABBV, The news for the past five days is as follows:
2018-08-31: NEWS1: Do the Risks in Marijuana Stocks Outweigh the Rewards?.NEWS2: Do the Risks in Marijuana Stocks Outweigh the Rewards?.NEWS3: Do the Risks in Marijuana Stocks Outweigh the Rewards?.NEWS4: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus.NEWS5: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus.NEWS6: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK&apos;s HIV Drug in Focus.NEWS7: 4 Large Cap Pharma Stocks in Focus on Robust Cancer Pipeline.
2018-09-04: NEWS1: Vertex Inks Reimbursement Agreement for Orkambi in Australia.NEWS2: Vertex Inks Reimbursement Agreement for Orkambi in Australia.NEWS3: These Monthly Dividend Stocks Are Set to Surge (and pay up to 6.8%).NEWS4: These Monthly Dividend Stocks Are Set to Surge (and pay up to 6.8%).NEWS5: Is Now a Good Time to Buy Gilead Sciences?.NEWS6: Is Now a Good Time to Buy Gilead Sciences?.NEWS7: AbbVie Reinforces Leadership in Dermatology With New Data Showcasing Research Advancements Across Growing Portfolio at the 27th European Academy of Dermatology and Venereology (EADV) Congress.NEWS8: Is Now a Good Time to Buy Gilead Sciences?.
2018-09-05: NEWS1: Top 5 Biotech Stocks for 2018.NEWS2: SHAREHOLDER ALERT: TSLA LOGM GLCNF ACAD MD FPI RMTI ABBV GDS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines.NEWS3: Forget CRISPR Therapeutics: Vertex Pharmaceuticals Incorporated Is a Better Biotech Stock.NEWS4: Forget CRISPR Therapeutics: Vertex Pharmaceuticals Incorporated Is a Better Biotech Stock.NEWS5: SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) and Lead Plaintiff Deadline – September 24, 2018.
2018-09-06: NEWS1: Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status.NEWS2: Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status.NEWS3: Notable ETF Inflow Detected - MTUM, BA, JPM, ABBV.NEWS4: Notable ETF Inflow Detected - MTUM, BA, JPM, ABBV.NEWS5: 3 Top Big Pharma Stocks to Buy Now.NEWS6: 3 Top Big Pharma Stocks to Buy Now.NEWS7: 3 Top Big Pharma Stocks to Buy Now.
2018-09-07: NEWS1: Daily Dividend Report: AMT, RCL, ABBV, AMAT, NUE, KRC.NEWS2: Daily Dividend Report: AMT, RCL, ABBV, AMAT, NUE, KRC.NEWS3: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, ABBV and FB.NEWS4: Vertex Completes Enrollment in Triple Combination Studies.NEWS5: Vertex Completes Enrollment in Triple Combination Studies.NEWS6: AbbVie Declares Quarterly Dividend.NEWS7: Vertex Completes Enrollment in Triple Combination Studies.NEWS8: Lilly, Teva, Pfizer & Others Await FDA Decisions in September.NEWS9: Jim Cramer Weighs In On CarMax, AbbVie And More.

Answer: Decrease